Increased risk of erectile dysfunction with semaglutide in non-diabetic obese patients

FHS
May 27, 2024
1:08 am

Researchers found that semaglutide treatment for weight loss in non-diabetic, obese men is associated with an increased risk of erectile dysfunction and testosterone deficiency.

Headwinds Aren’t Yet Lifting

You’re reading a copy of this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter

June 26, 2023

Scientists develop tissue adhesive gelatin hydrogels to speed up wound healing, prevent infections

Open wounds, whether caused by accidents or from medical procedures like surgery, require proper management to speed up healing and prevent infections.

November 6, 2023

Antibiotic for Treating Sepsis Linked to Increased Mortality

In adults hospitalized with suspected sepsis, piperacillin-tazobactam was associated with a higher mortality rate and increased duration in organ dysfunction compared with cefepime, according to

May 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.